Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 1901–1950 of 33814
On May 1, 2026, Richard C. Breeden notified STERIS plc (the “Company”) that he will not stand for reelection to the Board of Directors (the “Board”) at the Company’s 2026 Annual General Meeting of Shareholders.
On May 7, 2026, Six Flags Entertainment Corporation (the “Company”) announced the departures of Brian Witherow, the Chief Financial Officer of the Company, and Brian Nurse, the Chief Legal and Compliance Officer of the Company, effective May 8, 2026.
On May 7, 2026, Six Flags Entertainment Corporation (the “Company”) announced the departures of Brian Witherow, the Chief Financial Officer of the Company, and Brian Nurse, the Chief Legal and Compliance Officer of the Company, effective May 8, 2026.
On May 3, 2026 (the “ Termination Date ”), independent director Oleh Nabyt resigned from the Board of Directors of Shuttle, effective as of the Termination Date.
Sheen Khoury was terminated as the Executive Vice President, Worldwide Sales and Marketing of A10 Networks, Inc. (the “Company”) on April 27, 2026, effective immediately.
succeeding Mr. Joel L. Fruendt, the current President and Chief Executive Officer of the Company.
On May 1, 2026, Adam Appleby informed Registrant that he will be resigning from his position as Executive Vice President, Public Sector Solutions, to pursue other professional endeavors, effective May 19, 2026.
Evangelos Perros, Chief Financial Officer, has decided to step down from his role with the Company effective June 15, 2026.
announcing the departure of Jay Flynn, Executive Vice President and General Manager, Research and Learning, and the appointment of Jessica Kowalski, Executive Vice President and General Manager, Research, effective May 11, 2026.
Lawrence A. Barbetta, a member of the Board of Directors (the “Board”) of Winmark Corporation (the “Company”) notified the Company that he will not stand for re-election at the Company’s Annual Meeting of Shareholders to be held on or about April 21, 2027, in accordance with the Company’s independent director term limits.
On May 4, 2026, United States Antimony Corporation (the "Company") announced that Richard Isaak, the Company's Chief Financial Officer and principal financial officer, will commence a personal leave of absence effective immediately.
On May 6, 2026, Jared Shure provided notice to The Children’s Place, Inc. (the “Company”) that he will be leaving his positions as Chief Administrative Officer, General Counsel and Corporate Secretary, effective June 1, 2026.
On May 5, 2026, Mr. Michael R. Cannon notified the Board of Directors (the “Board”) of Seagate Technology Holdings, plc (the “Company”) that he has decided not to stand for re-election to the Board at the Company’s 2026 Annual General Meeting of Shareholders (the “Annual Meeting”).
Effective April 30, 2026, Ethan Rudin, the Chief Financial Officer of Bright Mountain Media, Inc. (the “Company”), departed from the Company and his role as Chief Financial Officer.
Kirk K. Calhoun was not nominated for re-election to the Board at the Annual Meeting, and effective as of April 30, 2026, he ceased to serve as a director of the Company.
On April 30, 2026, Flutter Entertainment plc (“Flutter”) agreed to have Amy Howe, Chief Executive Officer of FanDuel Inc. (“FanDuel”) leave the employment of FanDuel.
On May 4, 2026, Andrew S. Hughes, our General Counsel and Corporate Secretary, notified us of his intent to resign from his employment at AEye, Inc. (the “Company”), effective May 15, 2026, to accept a position at an employer in an unrelated industry.
On May 5, 2026 Ashley Zumwalt-Forbes resigned from her role as Chief Operating Officer and Director of Evolution Global Acquisition Corp.
On May 3, 2026, Cesar Soriano notified the board of directors of eHealth, Inc. (the “Board”) of his decision to resign from the Board, including all committees thereof, effective immediately prior to the commencement of the Company’s 2026 Annual Meeting of Stockholders currently scheduled for June 18, 2026, at 9:00 a.m. Eastern Time.
On May 5, 2026 (the “Effective Date”), Bionano Genomics, Inc. (the “Company”) R. Erik Holmlin, Ph.D. was terminated as the Company’s President and Chief Executive Officer, effective immediately.
David Moon, President and Chief Executive Officer of the Company, has notified the Board of Directors (the “Board”) of his intention to retire following the appointment of his replacement.
On May 4, 2026, Mike Mancini, Chief Financial Officer of the Company, submitted his resignation to the Company effective as of May 6, 2026.
On May 2, 2026, Mark Jung submitted his resignation as a member of the Board of Directors and the audit committee of the Company (the " Board "), effective on May 6, 2026.
Following the Committee’s review and recommendation, the Independent Board of Directors approved the termination of Mr. Perry’s employment for Cause, with notice of such termination delivered on May 2, 2026.
On May 1, 2026, Fiona Fitzmaurice ceased serving as Chief Financial Officer of Birchtech Corp.
On May 4, 2026, Anthony K. McDonald, the Company’s President and a member of the Company’s Board of Directors, resigned as President and as a director of the Company.
On May 4, 2026, Anthony K. McDonald, the Company’s President and a member of the Company’s Board of Directors, resigned as President and as a director of the Company.
effective upon the retirement of Thomas R. Quinn, Jr. from those positions with the Company and the Bank at the close of business on June 1, 2026
On May 5, 2026, the Board of Directors of SkinHealth Systems Inc. (the “Company”) terminated Mr. Ronald Menezes' employment as Chief Revenue Officer of the Company without cause, effective as of May 5, 2026.
On April 30, 2026, a special committee (the "Special Committee") composed of independent directors of the Board of Directors (the "Board") of Anavex Life Sciences Corp. (the "Company") terminated the employment of Christopher Missling, PhD as the Company's Chief Executive Officer for Cause (as defined in the Employment Agreement, dated as of June 27, 2013, between Dr. Missling and the Company, as amended and restated), effective immediately, for, among other things, conduct that the Special Committee believed was inconsistent with Company policy.
Dr. Essig succeeds Mojdeh Poul, who is departing from her role as the Company's President and Chief Executive Officer and as a member of the Company's Board of Directors (the "Board") effective as of the end of the day on April 30, 2026 (the "Separation Date").
Dr. Essig succeeds Mojdeh Poul, who is departing from her role as the Company's President and Chief Executive Officer and as a member of the Company's Board of Directors (the "Board") effective as of the end of the day on April 30, 2026 (the "Separation Date").
On May 5, 2026, Option Care Health, Inc. (the “Company”) announced that Christopher L. Grashoff will depart from his role as Chief Growth Officer of the Company, effective May 8, 2026.
On May 5, 2026, Resources Connection, Inc. (the “Company”) announced the retirement of A. Robert Pisano
David Klein will depart from his position as General Counsel and Secretary of the Company, effective May 31, 2026.
each of David A. Pace, John Moore, Bradley Radoff, Shaun Mara, Terence O'Brien, and Waheed Zaman, the members of the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company at the Effective Time
each of David A. Pace, John Moore, Bradley Radoff, Shaun Mara, Terence O'Brien, and Waheed Zaman, the members of the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company at the Effective Time
each of David A. Pace, John Moore, Bradley Radoff, Shaun Mara, Terence O'Brien, and Waheed Zaman, the members of the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company at the Effective Time
each of David A. Pace, John Moore, Bradley Radoff, Shaun Mara, Terence O'Brien, and Waheed Zaman, the members of the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company at the Effective Time
each of David A. Pace, John Moore, Bradley Radoff, Shaun Mara, Terence O'Brien, and Waheed Zaman, the members of the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company at the Effective Time
each of David A. Pace, John Moore, Bradley Radoff, Shaun Mara, Terence O'Brien, and Waheed Zaman, the members of the board of directors of the Company immediately prior to the Effective Time, ceased to be directors of the Company at the Effective Time
mutually agreed that Ms. Schum’s last day of employment with B&G Foods would be May 1, 2026.
On May, 1, 2026, Andrew D. Vogel, our Executive Vice President and President of Spices & Flavor Solutions, terminated his employment with B&G Foods as of the close of business that day.
On April 29, 2026, J. Ross Franklin notified Atlantic American Corporation (the “Company”) of his decision to resign as Vice President, Chief Financial Officer and Secretary of the Company, effective May 27, 2026.
Effective upon Mr. Ware’s appointment as the CFO, Justin Vu resigned as Chief Financial Officer of the Company as well as all other positions with the Company, its subsidiaries and its affiliates.
As a result, Yann Brandt departed as the Company’s President and Chief Executive Officer and as a Company director, effective as of April 29, 2026.
Yann Brandt departed as the Company’s President and Chief Executive Officer and as a Company director, effective as of April 29, 2026.
Christopher W. Silcock, President, Global Brands & Commercial Services, intends to retire from the Company in the first quarter of 2027.
each of Robert Azelby, Amy Burroughs, David Fellows, Jeffrey B. Kindler, J.D., Jill M. Quigley, J.D., Radhika Tripuraneni, M.D. and Heather Turner, J.D. ceased to be a member of the Board of Directors of Terns
each of Robert Azelby, Amy Burroughs, David Fellows, Jeffrey B. Kindler, J.D., Jill M. Quigley, J.D., Radhika Tripuraneni, M.D. and Heather Turner, J.D. ceased to be a member of the Board of Directors of Terns
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.